title: The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.
abstract: OBJECTIVE
  To identify the relationship of erectile dysfunction, hypogonadism and the metabolic syndrome in the context of men's health.
  
  
  METHODS
  An Expert Panel Meeting was held in December 2006 in Vienna, Austria. In addition a comprehensive literature search was conducted.
  
  
  RESULTS
  Men have a higher incidence of cardiovascular events than women of similar ages which has led to the belief that testosterone is a risk factor for cardiovascular disease in men. The latter hypothesis is no longer tenable. On the contrary, low testosterone levels are associated with (visceral) obesity, the metabolic syndrome, diabetes mellitus, cardiovascular disease and erectile dysfunction (ED). Testosterone therapy does not lead to an increased incidence of cardiovascular disease or events such as myocardial infarction, stroke or angina. Until recently (visceral) obesity, the metabolic syndrome, diabetes mellitus, cardiovascular disease and ED were viewed as more or less independent entities affecting the ageing male. It was not recognised that hypogonadism is a common denominator. With a more integrative approach to the health situation of middle-aged and elderly men, these conditions appear closely interrelated in their manifestations, hypothetically in their aetiology, diagnostic strategy and also their treatment.
  
  
  CONCLUSIONS
  Improving sexual health is a portal to identify health hazards and improving men's health. Appropriate diagnosis and medical work up of men presenting with sexual symptoms may have the benefit of the diagnosing and treating other important conditions, such as obesity, diabetes, hypertension and hyperlipidaemia.
authors.affiliation: Division of Urology, Maimonides Medical Center, Columbia University, Brooklyn, NY 11219, USA. rshabsigh@maimonidesmed.org
authors.forename: R
authors.initials: R
authors.lastname: Shabsigh
authors.forename: S
authors.initials: S
authors.lastname: Arver
authors.forename: K S
authors.initials: KS
authors.lastname: Channer
authors.forename: I
authors.initials: I
authors.lastname: Eardley
authors.forename: A
authors.initials: A
authors.lastname: Fabbri
authors.forename: L
authors.initials: L
authors.lastname: Gooren
authors.forename: A
authors.initials: A
authors.lastname: Heufelder
authors.forename: H
authors.initials: H
authors.lastname: Jones
authors.forename: S
authors.initials: S
authors.lastname: Meryn
authors.forename: M
authors.initials: M
authors.lastname: Zitzmann
mesh_terms: D000368:Aged; D015897:Comorbidity; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis / Q000453:epidemiology*; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000453:epidemiology*; D008875:Middle Aged; D013739:Testosterone / Q000097:blood
chemical_list: D013739:Testosterone